科研成果

发表论文

开始时间:
结束时间:
编号 论文名称 第一作者 通讯作者 刊物名称 影响因子
1 Differentialand Prognostic Significance of HOXB7 in Gliomas 周新刚 王鹏 Frontiers in Cell and Developmental Biology 2021 6.684
2 Transarterial Chemoembolization Plus Lenvatinib Versus Transarterial Chemoembolization Plus Sorafenib as First-Line Treatment for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Prospective Randomized Study 丁晓燕 陈京龙 Cancer 2021 6.86
3 Altered T-Cell Subsets are Associated with Dysregulated Cytokine Secretion of CD4 + T Cells During HIV Infection 汪笛 赵红心 Journal of Inflammation Research. 2021 6.922
4 Yindan Jiedu Granules, a Traditional Chinese Medicinal Formulation, as a Potential Treatment for Coronavirus Disease 2019 刘景院 王宪波 Frontiers in Immunology 2021 7.561
5 Persistent High Percentage of HLA-DR + CD38 high CD8 + T Cells Associated With Immune Disorder and Disease Severity of COVID-19 杜娟 孔雅娴 Frontiers in Immunology 2021 7.561
6 Single-cell sequencing reveals the novel role of Ezh2 in NK cell maturation and function 于明航 王玺 Frontiers in Immunology 2021 7.561
7 Microbiome Profiling Using Shotgun Metagenomic Sequencing Identified Unique Microorganisms in COVID-19 Patients With Altered Gut Microbiota 杨思园 王凌航 Frontiers in Immunology 2021 7.561
8 Application of Lab-on-Chip for Detection of Microbial Nucleic Acid in Food and Environment. Frontiers in Microbiology 杨柳 李明慧 Frontiers in Immunology 2021 7.561
9 TIGIT+ TIM-3+ NK cells are correlated with NK cell exhaustion and disease progression in patients with hepatitis B virus‑related hepatocellular carcinoma 于莉华 杨志云 Oncoimmunology 2021 8.11
10 The effect of concomitant use of statins, NSAIDs, low-dose aspirin, metformin and beta-blockers on outcomes in patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis 张永超 李威 Oncoimmunology 2021 8.11